The healthcare industry has shifted fundamentally from reactive treatment to proactive, precise, and decentralized management. At the heart of this revolution lies the diagnostic sector, the assays, point-of-care devices, and molecular kits that guide clinical decisions daily. Yet, as the complexity of these diagnostics scales, original equipment manufacturers (OEMs) face a challenging hurdle:...